https://www.indianpharmapost.com/uk-relonchem-receives-marketing-authorization-for-levonorgestrel-15-mg-tablets-159762024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/sms-pharmaceuticals-reports-q1-fy25-consolidated-pat-at-rs-1648-cr-159842024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/cupid-post-q1-fy25-profit-at-rs-825-cr-159832024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/indraprastha-medical-corporation-posts-q1-fy25-pat-at-rs-4477-cr-159822024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/vijaya-diagnostic-centre-reports-q1-fy25-consolidated-pat-at-rs-3134-cr-159812024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/onesource-and-brl-ink-technology-licensing-agreement-to-deliver-high-concentration-biologics-subcutaneously-159802024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-usfda-approval-for-prednisolone-acetate-ophthalmic-suspension-usp-159792024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-completes-successful-phase-3-trials-for-lucentis-biosimilar-159782024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/narayana-hrudayalaya-posts-q1-fy25-consolidated-pat-higher-at-rs-20137-cr-159772024-08-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurobindo-pharma-receives-usfda-approval-for-estradiol-vaginal-inserts-usp-10-mcg-159852024-08-06T00:00:00+05:30always0.9